Berwyn Clarke

Berwyn Clarke

Chairman at Novai Ltd.

68 year
Health Technology
Health Services
Commercial Services

Profile

Berwyn Ewart Clarke was the founder of Lab 21 Ltd.
(founded in 2005) and held the title of Director, Chief Scientific & Development Officer from 2012 to 2013.
Dr. Clarke is also the founder of Oneida TheraDiagnostics Ltd.
Dr. Clarke's current job(s) include being the Chairman of Iceni Diagnostics Ltd., Co-Chairman of Novai Ltd., and Director of PBD Biotech Ltd.
(since 2014).
Dr. Clarke's former job(s) include being the Interim Chief Executive Officer of Replizyme Ltd., Director of Glyconics Ltd.
(from 2013 to 2023), and holding positions at Wellcome Plc and Virco Group.
Dr. Clarke obtained a doctorate degree from Imperial College London and an undergraduate degree from the University of Kent.

Berwyn Clarke active positions

CompaniesPositionStart
Director/Board Member 2014-02-16
Chairman -
Chairman -
All active positions of Berwyn Clarke

Former positions of Berwyn Clarke

CompaniesPositionEnd
Director/Board Member 2023-08-28
Founder 2013-01-30
Replizyme Ltd. President -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Berwyn Clarke's experience

Training of Berwyn Clarke

Imperial College London Doctorate Degree
University of Kent Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Berwyn Clarke's experience

Connections

26

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies9

Health Services

Oneida TheraDiagnostics Ltd.

Commercial Services

Health Services

Replizyme Ltd.

Health Technology

Health Technology

Health Technology

Commercial Services

See company connections